Explore Insights on Psoriatic Arthritis

1 in 3 people with psoriasis will develop Psoriatic arthritis

Psoriatic arthritis (PsA) is a chronic inflammatory condition that
affects millions globally. The prevalence of PsA has been researched
extensively, indicating significant presence in different parts of the
world. Recent studies suggest that PsA affects approximately 112 out of
every 100,000 adults, with a distinct variation in prevalence across
continents. It is notably more prevalent in Europe and North America
compared to Asia and South America.

What are the current treatments for Psoriatic Arthritis?

Stay informed with Safety Shield about the latest and traditional treatments for psoriatic arthritis (PsA). Receive regular updates on the status and efficacy of these therapeutic approaches, ensuring you have the most current and comprehensive insights.
1 6
View all

Discover who is currently working on the subject

Expert mapping will allow you to access to the most active expects on the subject and the recruiting sites.

Example product title

View full details

Discover Clinical Endpoints for Psoriatic Arthrisis

The Clinical Endpoint Report for Vitiligo provides a detailed analysis of clinical trial endpoints, treatment strategies, and patient outcomes in vitiligo research. Sourced from ClinicalTrials.gov, it highlights trends in FDA-based clinical outcome assessments.
1 3

ArcaShop

Clinical Endpoints Study for PSORIATIC ARTHRITIS

Output format
View full details

You want a tailored analysis for Psoriatic Arthritis?

Reach out to us to make an on demand customized analysis for your needs.

Learn more